Home › Funds › Brighthouse › MetLife MSCI EAFE Index Portfolio
Fund family: Brighthouse · Filed by Brighthouse Funds Trust II (CIK 710826) · SEC series S000006521
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 10,529 with, 700 against, 22 abstentions (not counted as with management); 823 items carried no recommendation; 7 split votes are in neither count. Shareholder proposals: 62 FOR, 134 AGAINST, 6 abstained, by the filing’s own vote-source field.
The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Brighthouse | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 92.5% | 8,753 | 76.3% | 204,500 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 12.8% | 1,182 |
Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Brighthouse funds on 28 items (1.0% of the 2,825 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Marie-Josée Kravis as Director | Against | FOR — 4 of 4 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Delphine Arnault as Director | Against | FOR — 5 of 7 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Laurent Mignon as Director | Against | FOR — 5 of 7 Brighthouse funds | For | — |
| Atlas Copco AB | 2026-04-28 | Reelect Hans Straberg as Board Chair | Against | FOR — 4 of 6 Brighthouse funds | For | — |
| Atlas Copco AB | 2026-04-28 | Reelect Hans Straberg as Director | Against | FOR — 4 of 6 Brighthouse funds | For | — |
| Atlas Copco AB | 2026-04-28 | Reelect Peter Wallenberg Jr as Director | Against | FOR — 4 of 6 Brighthouse funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reelect Anton Rupert as Director | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| Compagnie Financiere Richemont SA | 2025-09-10 | Reelect Johann Rupert as Director and Board Chair | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Compensation of Bernard Arnault, Chairman and CEO | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Remuneration Policy of Chairman and CEO | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Authorize up to 1 Percent of Issued Capital for Use in Restricted Stock Plans | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Authorize up to 1 Percent of Issued Capital for Use in Stock Option Plans | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Natacha Valla as Director | Against | FOR — 4 of 7 Brighthouse funds | For | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Britt Meelby Jensen as New Director | Abstain | FOR — 3 of 5 Brighthouse funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Cees de Jong (Vice Chair) as New Director | Abstain | FOR — 3 of 5 Brighthouse funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Mikael Dolsten as New Director | Abstain | FOR — 3 of 5 Brighthouse funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Stephan Engels as New Director | Abstain | FOR — 3 of 5 Brighthouse funds | — | — |
| Banco Santander SA | 2026-03-26 | Approve Non-Financial Information Statement | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Enel SpA | 2026-05-12 | Shareholder Slate Submitted by Institutional Investors (Assogestioni) | For | AGAINST — 2 of 3 Brighthouse funds | — | — |
| Aena S.M.E. SA | 2026-04-16 | Advisory Vote on Company's 2025 Updated Report on Climate Action Plan | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Aena S.M.E. SA | 2026-04-16 | Approve Non-Financial Information Statement | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Avolta AG | 2026-05-06 | Approve Non-Financial Report | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| CaixaBank SA | 2026-03-26 | Approve Non-Financial Information Statement | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Continental AG | 2026-04-30 | Reelect Sabine Neuss to the Supervisory Board | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| Ferrari NV | 2026-04-15 | Reelect Piero Ferrari as Non-Executive Director | Against | FOR — 2 of 3 Brighthouse funds | For | — |
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Galderma Group AG | 2026-04-22 | Approve Non-Financial Report | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Holcim Ltd. | 2026-05-13 | Approve Sustainability Report | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
| Novonesis (Novozymes A/S) | 2026-03-23 | Reelect Heine Dalsgaard (Vice Chair) as Director | For | ABSTAIN — 2 of 3 Brighthouse funds | For | — |
Download all 28 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 4,842 | 363 |
| Corporate Governance | 2,841 | 67 |
| Compensation | 1,718 | 189 |
| Capital Structure | 1,625 | 54 |
| Audit-related | 653 | 18 |
| Other | 280 | 1 |
| Extraordinary Transactions | 69 | 1 |
| Other Social Issues | 60 | 0 |
| Environment or Climate | 53 | 2 |
| Shareholder Rights and Defenses | 18 | 5 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 18, 2026 | NTT, Inc. | Amend Articles to Ensure Equal Treatment of Management Proposals and Shareholder Proposals in Voting via the Internet Shareholder proposal | For | Against |
| June 18, 2026 | NTT, Inc. | Amend Articles to Relax Limit of Number of Characters in Shareholder Proposal Justification Statements Shareholder proposal | For | Against |
| April 23, 2026 | BP Plc | Adopt New Articles of Association | Against | For |
| April 23, 2026 | BP Plc | Approve Revocation of Resolution 25 (2015) and Resolution 22 (2019) | Against | For |
| June 1, 2026 | The Hong Kong and China Gas Company Limited | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Against | For |
| June 26, 2026 | Mitsubishi UFJ Financial Group, Inc. | Elect Director Shimizu, Hiroshi | Against | For |
| June 26, 2026 | Mitsubishi UFJ Financial Group, Inc. | Elect Director Ueda, Teruhisa | Against | For |
| May 8, 2026 | WH Group Limited | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Against | For |
| May 8, 2026 | WH Group Limited | Authorize Reissuance of Repurchased Shares | Against | For |
| May 29, 2026 | Iberdrola SA | Approve Long-Term Incentive Plan | Against | For |
| April 28, 2026 | Atlas Copco AB | Reelect Hans Straberg as Director | Against | For |
| April 28, 2026 | Atlas Copco AB | Reelect Peter Wallenberg Jr as Director | Against | For |
12,170 ballot items at 728 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, MetLife MSCI EAFE Index Portfolio voted at 728 shareholder meetings of 677 companies, on 12,170 ballot items in all. Where management made a recommendation, the fund followed it on 93.6% of the items and voted against it 700 times. Its most frequent area of disagreement was director elections (363 of its votes against management). It voted FOR 31.6% of the 196 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (92.5% against 76.3%). It voted differently from most Brighthouse funds on 28 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.